Contact this trialFirst, we need to learn more about you.
Antisense Oligonucleotide
High-Dose Nusinersen for Spinal Muscular Atrophy
Recruiting2 awardsPhase 3
Atlanta, Georgia
This trial is testing a new drug for spinal muscular atrophy and its effects on motor function. The safety and tolerability of the drug will also be monitored.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.